BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17909108)

  • 21. Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice.
    Westerterp M; Berbée JF; Pires NM; van Mierlo GJ; Kleemann R; Romijn JA; Havekes LM; Rensen PC
    Circulation; 2007 Nov; 116(19):2173-81. PubMed ID: 17967778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.
    Smith E; Prasad KM; Butcher M; Dobrian A; Kolls JK; Ley K; Galkina E
    Circulation; 2010 Apr; 121(15):1746-55. PubMed ID: 20368519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The enhanced expression of IL-17-secreting T cells during the early progression of atherosclerosis in ApoE-deficient mice fed on a western-type diet.
    Jeon US; Choi JP; Kim YS; Ryu SH; Kim YK
    Exp Mol Med; 2015 May; 47(5):e163. PubMed ID: 25976521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
    Liu SL; Li YH; Shi GY; Tang SH; Jiang SJ; Huang CW; Liu PY; Hong JS; Wu HL
    Cardiovasc Res; 2009 Apr; 82(1):161-9. PubMed ID: 19189960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of natural killer T cell activation on the initiation of atherosclerosis.
    van Puijvelde GH; van Wanrooij EJ; Hauer AD; de Vos P; van Berkel TJ; Kuiper J
    Thromb Haemost; 2009 Aug; 102(2):223-30. PubMed ID: 19652872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.
    Ortiz MA; Campana GL; Woods JR; Boguslawski G; Sosa MJ; Walker CL; Labarrere CA
    Exp Biol Med (Maywood); 2009 Jun; 234(6):624-31. PubMed ID: 19359657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
    Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice.
    Koga M; Kai H; Yasukawa H; Yamamoto T; Kawai Y; Kato S; Kusaba K; Kai M; Egashira K; Kataoka Y; Imaizumi T
    Circ Res; 2007 Aug; 101(4):348-56. PubMed ID: 17495225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.
    Schieffer B; Selle T; Hilfiker A; Hilfiker-Kleiner D; Grote K; Tietge UJ; Trautwein C; Luchtefeld M; Schmittkamp C; Heeneman S; Daemen MJ; Drexler H
    Circulation; 2004 Nov; 110(22):3493-500. PubMed ID: 15557373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A functional role for inducible costimulator (ICOS) in atherosclerosis.
    Afek A; Harats D; Roth A; Keren G; George J
    Atherosclerosis; 2005 Nov; 183(1):57-63. PubMed ID: 15941568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
    Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
    Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis.
    Norata GD; Marchesi P; Pulakazhi Venu VK; Pasqualini F; Anselmo A; Moalli F; Pizzitola I; Garlanda C; Mantovani A; Catapano AL
    Circulation; 2009 Aug; 120(8):699-708. PubMed ID: 19667236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
    Zhao Y; Kuge Y; Zhao S; Strauss HW; Blankenberg FG; Tamaki N
    J Nucl Med; 2008 Oct; 49(10):1707-14. PubMed ID: 18794270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic response enhances atherosclerosis-type 1 helper T cell (Th1)-to-type 2 helper T cell (Th2) shift and calcified atherosclerosis in Bacillus Calmette-Guerin (BCG)-treated apolipoprotein E-knockout (apo E-/-) mice.
    Shibata Y; Ohata H; Yamashita M; Tsuji S; Bradfield JF; Nishiyama A; Henriksen RA; Myrvik QN
    Transl Res; 2007 Feb; 149(2):62-9. PubMed ID: 17240316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden.
    Liu P; Yu YR; Spencer JA; Johnson AE; Vallanat CT; Fong AM; Patterson C; Patel DD
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):243-50. PubMed ID: 18079406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
    Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
    Desai A; Zhao Y; Warren JS
    Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIF-1alpha overexpression and experimental murine atherosclerosis.
    Ben-Shoshan J; Afek A; Maysel-Auslender S; Barzelay A; Rubinstein A; Keren G; George J
    Arterioscler Thromb Vasc Biol; 2009 May; 29(5):665-70. PubMed ID: 19251587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.